SINTX Technologies (SINT) Osake Kurssi

SINTX Technologies, Inc. generates revenue by manufacturing and selling silicon nitride-based orthopedic medical devices. The company focuses on vertically integrated production of silicon nitride ceramic technology for hip and knee arthroplasty components, including solid, porous, composite, and coated forms. Its primary customers are surgeons and hospitals in the United States, Europe, and South America, who purchase these wear- and corrosion-resistant implant components for total hip and knee replacement procedures. The firm markets its products directly to healthcare providers through its established distribution channels in target markets. The company's revenue stream is derived from the sale of silicon nitride ceramic technology platforms used in medical devices, with a specific emphasis on orthopedic applications. By developing and producing implant components that incorporate silicon nitride, SINTX addresses the need for durable, high-performance materials in joint replacement surgeries. This approach allows the company to target the growing market for advanced orthopedic solutions in key regions. SINTX Technologies, Inc. operates as a commercial biomaterial company specializing in silicon nitride ceramic technology. Its product portfolio includes components for total hip and knee replacement systems, which are sold to healthcare institutions globally. The firm's vertically integrated manufacturing model ensures control over the production of silicon nitride materials, enabling consistent quality and innovation in its medical device offerings.